QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study 会议论文 60th Annual Meeting of the American-Society-of-Hematology (ASH), DEC 01-04, 2018 作者:  Angelucci, Emanuele;  Li, Junmin;  Greenberg, Peter L.;  Depei, Wu;  Hou, Ming 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/31 A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia 期刊论文 INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 卷号: 96, 期号: 2, 页码: 222-228 作者:  Wang, Shujie;  Yang, Renchi;  Zou, Ping;  Hou, Ming;  Wu, Depei 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/23 Primary immune thrombocytopenia (ITP)  Thrombopoietin (TPO)  Recombinant  human thrombopoietin (rhTPO)   Homoharringtonine-Based Induction Regimens for Patients with De Novo Acute Myeloid Leukemia: A Multicenter Randomized Controlled Phase 3 Trial 会议论文 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), DEC 08-11, 2012 作者:  Jin, Jie;  Wang, Jianxiang;  Chen, Feifei;  Wu, Depei;  Hu, Jiong 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/31